Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05112341

Enrollment

Registered

2021-11-08

Start date

2021-06-01

Completion date

2023-10-01

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Study on Breast Cancer Patients

Brief summary

the study aiming for compairing results of hypofractionaton radiotherapy treatment in patient with early breast cancer between two arms the first arm recieving five fractions and the other arm recieving fifteen fraction

Interventions

RADIATIONradiation therapy

the patient first is simulated then delineation is done

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* age group ( 18-80) years * breast conservation surgery * Stages (pT1-3, pN0-1, M0) breast cancer. * Any histological type of invasive breast cancer. * All grades of breast cancer (I,II,III)

Exclusion criteria

* Stage (III or IV) breast cancer. * Metastatic breast cancer (MBC) * Recurrent breast cancer. * Patients' co-morbidities that contraindicate radiotherapy

Design outcomes

Primary

Measure	Time frame	Description
1-disease free survival	2 years	the time free from disease
2- overall survival	2 years	the period time from treatment till death
3- toxicity from treatment	2 years	side effects from treatment

Countries

Egypt

Contacts

Primary Contactheba a abdelal, assistant lecturer

hebaelsagheer@yahoo.com01062162612

Backup Contactmohamed s gaber, professor

01025876769

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026